Navigation Links
Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress

CHICAGO, Oct. 12 /PRNewswire/ -- Ethicon Endo-Surgery, Inc., today unveiled its broad portfolio of energy delivery devices at the 95th Annual Clinical Congress of the American College of Surgeons (ACS). The complementary energy technologies of worldwide leading HARMONIC® ultrasonic and ENSEAL® advanced bipolar devices provide surgeons with multiple energy delivery options that provide superior energy application for desired tissue effects to meet specific surgical needs across multiple surgical specialties. Ethicon Endo-Surgery acquired the ENSEAL® technology in October 2008; the ACS Annual Clinical Congress marks the full integration of the ENSEAL® product line into the Ethicon Endo-Surgery energy portfolio.

"I believe energy is the future of surgery, which is why we're seeing such significant advances in both bipolar and ultrasonic energy, which enhance the experience of surgeons and patients alike," said Michael J. Stamos, MD, FACS, FASCRS, chief, Division of Colon & Rectal Surgery, Department of Surgery, University of California, Irvine. "Since each patient case is unique, it is imperative to understand the distinctive attributes of each different energy technology. It also is critical to have the confidence and flexibility to choose the right modality to achieve optimal outcomes for both patients and for surgeons in terms of greater precision and control, maximized surgical efficiency and best tissue effect."

As energy delivery device options have evolved, they have enabled more efficient and minimally invasive surgical techniques. Ethicon Endo-Surgery, originally with HARMONIC® technology and now ENSEAL®, has led this evolution of surgery by working directly with surgeons to develop innovations, enabling greater functionality, controlled tissue sealing, and minimization of tissue trauma.

With its bipolar technology, ENSEAL® offers superior control in large vessel sealing for surgical procedures in general, colorectal, gynecology, and urology where minimal tissue damage is critical. Pre-clinical studies have shown ENSEAL® laparoscopic and open devices contain energy spread and are faster at sealing and transecting than competitive devices, while offering exceptional large vessel sealing (up to and including 7mm blood vessels).

As the leading ultrasonic cutting and coagulating surgical device used in more than 8 million surgical procedures worldwide since 1995, HARMONIC® allows precise application of ultrasonic energy in advanced laparoscopic and open procedures, and minimizes adjacent tissue damage to the patient. These devices are versatile and help the surgeon perform multiple surgical tasks with a single device that can lead to overall efficiency improvement over traditional techniques. HARMONIC® is indicated for multiple specialties and surgeries, including laparoscopic and open technique procedures within general, colorectal, gynecologic and urologic procedures, and often is credited with being the first device to enable some advanced laparoscopic procedures that general surgeons perform today.

"An increasing number of surgeons are applying the new technologies as standard of care for both laparoscopic and open procedures," said Kevin Lobo, worldwide president, Ethicon Endo-Surgery. "By offering both an ultrasonic and advanced bipolar technology, Ethicon Endo-Surgery delivers options to meet the needs of traditional and emerging surgical techniques."

About Ethicon Endo-Surgery

Ethicon Endo-Surgery develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at

SOURCE Ethicon Endo-Surgery, Inc.

SOURCE Ethicon Endo-Surgery, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Companys Toolbox
2. First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices
3. Ethicon Endo-Surgery Wins Prestigious International Design Award for Innovative Development of HARMONIC FOCUS(TM)
4. Ethicon Endo-Surgery Launches New Echelon Flex(TM) Endopath(R) Stapler That Delivers Echelon(TM) Compression, Now With Natural Articulation
5. Oregon Tourism Commission Unveils New Online Customer Service Training Program
6. NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
7. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
8. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
9. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
10. Boehringer Ingelheim Unveils Diabetes Pipeline
11. GNC Unveils Study Results for First and Only Nitric Oxide Product Clinically Proven to Improve Physical Performance at NSCA Conference in Las Vegas
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):